Supplemention with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats

Hong Jye Hong, George Hsiao, Tzu Hurng Cheng, Mao Hsiung Yen

Research output: Contribution to journalArticle

161 Citations (Scopus)

Abstract

It has been suggested that tetrahydrobiopterin (H4B), a cofactor of NO synthase, can reverse endothelial dysfunction caused by cardiovascular diseases, including atherosclerosis, coronary artery disease, and hypertension. Moreover, an impairment of H4B biosynthesis in spontaneously hypertensive rats (SHR) was observed. Thus, we hypothesized that the defect of the H4B synthesis system may play an important role in the development of hypertension in SHR. In the present study H4B (10 mg/kg per day IP) was used to treat SHR and Wistar-Kyoto rats (WKY) from the age of 5 through 16 weeks. Results demonstrated that chronic treatment with H4B significantly improved the impaired vascular responses to acetylcholine and suppressed the development of hypertension in SHR but did not affect WKY. The increase of inducible NO synthase expression, nitrotyrosine immunostaining, NO production, and superoxide anion formation in adult SHR were also significantly suppressed by chronic treatment with H4B. In contrast, H4B had no effect on WKY. In conclusion, this study demonstrated that H4B significantly attenuated the development of hypertension in SHR. The antihypertensive effect of H4B might be mediated through its direct antioxidant activity and/or decreasing oxygen free radical production from NO synthase, thereby reducing inducible NO synthase expression and peroxynitrite formation. Thus, the present study proposed that supplementation with H4B might be beneficial in preventing pathological conditions such as essential hypertension.

Original languageEnglish
Pages (from-to)1044-1048
Number of pages5
JournalHypertension
Volume38
Issue number5
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Inbred SHR Rats
Hypertension
Nitric Oxide Synthase
Inbred WKY Rats
Peroxynitrous Acid
Superoxides
Antihypertensive Agents
Acetylcholine
Free Radicals
Blood Vessels
sapropterin
Coronary Artery Disease
Reactive Oxygen Species
Atherosclerosis
Cardiovascular Diseases
Antioxidants

Keywords

  • Biopterin
  • Nitric oxide synthase
  • Peroxynitrite
  • Rats, inbred SHR
  • Superoxide

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Supplemention with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats. / Hong, Hong Jye; Hsiao, George; Cheng, Tzu Hurng; Yen, Mao Hsiung.

In: Hypertension, Vol. 38, No. 5, 2001, p. 1044-1048.

Research output: Contribution to journalArticle

Hong, Hong Jye ; Hsiao, George ; Cheng, Tzu Hurng ; Yen, Mao Hsiung. / Supplemention with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats. In: Hypertension. 2001 ; Vol. 38, No. 5. pp. 1044-1048.
@article{9b3d8c6b234546608313869f0857cc4a,
title = "Supplemention with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats",
abstract = "It has been suggested that tetrahydrobiopterin (H4B), a cofactor of NO synthase, can reverse endothelial dysfunction caused by cardiovascular diseases, including atherosclerosis, coronary artery disease, and hypertension. Moreover, an impairment of H4B biosynthesis in spontaneously hypertensive rats (SHR) was observed. Thus, we hypothesized that the defect of the H4B synthesis system may play an important role in the development of hypertension in SHR. In the present study H4B (10 mg/kg per day IP) was used to treat SHR and Wistar-Kyoto rats (WKY) from the age of 5 through 16 weeks. Results demonstrated that chronic treatment with H4B significantly improved the impaired vascular responses to acetylcholine and suppressed the development of hypertension in SHR but did not affect WKY. The increase of inducible NO synthase expression, nitrotyrosine immunostaining, NO production, and superoxide anion formation in adult SHR were also significantly suppressed by chronic treatment with H4B. In contrast, H4B had no effect on WKY. In conclusion, this study demonstrated that H4B significantly attenuated the development of hypertension in SHR. The antihypertensive effect of H4B might be mediated through its direct antioxidant activity and/or decreasing oxygen free radical production from NO synthase, thereby reducing inducible NO synthase expression and peroxynitrite formation. Thus, the present study proposed that supplementation with H4B might be beneficial in preventing pathological conditions such as essential hypertension.",
keywords = "Biopterin, Nitric oxide synthase, Peroxynitrite, Rats, inbred SHR, Superoxide",
author = "Hong, {Hong Jye} and George Hsiao and Cheng, {Tzu Hurng} and Yen, {Mao Hsiung}",
year = "2001",
language = "English",
volume = "38",
pages = "1044--1048",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Supplemention with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats

AU - Hong, Hong Jye

AU - Hsiao, George

AU - Cheng, Tzu Hurng

AU - Yen, Mao Hsiung

PY - 2001

Y1 - 2001

N2 - It has been suggested that tetrahydrobiopterin (H4B), a cofactor of NO synthase, can reverse endothelial dysfunction caused by cardiovascular diseases, including atherosclerosis, coronary artery disease, and hypertension. Moreover, an impairment of H4B biosynthesis in spontaneously hypertensive rats (SHR) was observed. Thus, we hypothesized that the defect of the H4B synthesis system may play an important role in the development of hypertension in SHR. In the present study H4B (10 mg/kg per day IP) was used to treat SHR and Wistar-Kyoto rats (WKY) from the age of 5 through 16 weeks. Results demonstrated that chronic treatment with H4B significantly improved the impaired vascular responses to acetylcholine and suppressed the development of hypertension in SHR but did not affect WKY. The increase of inducible NO synthase expression, nitrotyrosine immunostaining, NO production, and superoxide anion formation in adult SHR were also significantly suppressed by chronic treatment with H4B. In contrast, H4B had no effect on WKY. In conclusion, this study demonstrated that H4B significantly attenuated the development of hypertension in SHR. The antihypertensive effect of H4B might be mediated through its direct antioxidant activity and/or decreasing oxygen free radical production from NO synthase, thereby reducing inducible NO synthase expression and peroxynitrite formation. Thus, the present study proposed that supplementation with H4B might be beneficial in preventing pathological conditions such as essential hypertension.

AB - It has been suggested that tetrahydrobiopterin (H4B), a cofactor of NO synthase, can reverse endothelial dysfunction caused by cardiovascular diseases, including atherosclerosis, coronary artery disease, and hypertension. Moreover, an impairment of H4B biosynthesis in spontaneously hypertensive rats (SHR) was observed. Thus, we hypothesized that the defect of the H4B synthesis system may play an important role in the development of hypertension in SHR. In the present study H4B (10 mg/kg per day IP) was used to treat SHR and Wistar-Kyoto rats (WKY) from the age of 5 through 16 weeks. Results demonstrated that chronic treatment with H4B significantly improved the impaired vascular responses to acetylcholine and suppressed the development of hypertension in SHR but did not affect WKY. The increase of inducible NO synthase expression, nitrotyrosine immunostaining, NO production, and superoxide anion formation in adult SHR were also significantly suppressed by chronic treatment with H4B. In contrast, H4B had no effect on WKY. In conclusion, this study demonstrated that H4B significantly attenuated the development of hypertension in SHR. The antihypertensive effect of H4B might be mediated through its direct antioxidant activity and/or decreasing oxygen free radical production from NO synthase, thereby reducing inducible NO synthase expression and peroxynitrite formation. Thus, the present study proposed that supplementation with H4B might be beneficial in preventing pathological conditions such as essential hypertension.

KW - Biopterin

KW - Nitric oxide synthase

KW - Peroxynitrite

KW - Rats, inbred SHR

KW - Superoxide

UR - http://www.scopus.com/inward/record.url?scp=0035726142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035726142&partnerID=8YFLogxK

M3 - Article

C2 - 11711495

AN - SCOPUS:0035726142

VL - 38

SP - 1044

EP - 1048

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 5

ER -